Skip to main content

Financial Toxicity

Long-Term Financial Toxicity Has Substantial Impact on HRQoL Among Partners of Colorectal Cancer Survivors
In the Literature, Financial Toxicity
August 2023, Vol 13, No 8
A new study has found that partners of colorectal cancer survivors experienced long-term financial toxicity that was associated with worse health-related quality of life (HRQoL) due to systems- and individual-level behavioral factors. Read More ›
Financial Navigation Can Reduce the Financial Toxicity of Cancer Care
By Carmen Phillips
Financial Toxicity
June 2023, Vol 13, No 6
Results from a new study add to the evidence that programs aimed at reducing the financial burden of cancer treatment can save money and improve the quality of life of people with cancer and their loved ones. Read More ›
Financial Toxicity High for Low-Income Patients in Early-Phase Clinical Trials
By Chase Doyle
Financial Toxicity
November 2019, Vol 9, No 11
The economic burden faced by patients with cancer who have low income may be more pervasive than previously thought. According to data presented at the 2019 ASCO Quality Care Symposium, even patients enrolled in clinical trials are at high risk for financial toxicity. Read More ›
November 4, 2019 — Oncology News & Updates
By Yvette Florio Lane
Financial Toxicity, Genomic Testing, Leukemia, Head & Neck Cancers , In the Literature, Genetics & Genomics
Web Exclusives
  • Xospata Extends Overall Survival in Patients with FLT3 Mutation–Positive Relapsed or Refractory Acute Myeloid Leukemia
  • Published Results from KEYNOTE-048 Trial Show Extended Survival with Keytruda Advanced Head and Neck Cancers
  • Discussing Costs of Genomic Testing with Patients
Read More ›
What Drives Patient Preferences When Facing Financial Toxicity?
By Chase Doyle
Financial Toxicity
February 2019, Vol 9, No 2
The economic burden caused by cancer and its treatment affects more than the patient’s bank account. As studies have shown, financial toxicity can lead to reduced quality of life, compromise treatment, and worsen clinical outcomes, and the associated devastation can extend to caregivers as well. Read More ›
Addressing Financial Toxicity Through Systematic Change
By Meg Barbor, MPH
Financial Toxicity
December 2018, Vol 8, No 12
Although the cost of care can have severe effects on patients with cancer and their families, oncologists rarely address financial toxicity, according to Hanna K. Sanoff, MD, MPH, Medical Director, University of North Carolina (UNC) NC Cancer Hospital Clinics. Read More ›
Discussing Costs with Your Patient Can Reduce Financial Toxicity
By Chase Doyle
Financial Support, Financial Toxicity
July 2018, Vol 8, No 7
With healthcare premiums on the rise and out-of-pocket costs skyrocketing, almost every person diagnosed with cancer is at risk for being underinsured, but this threat extends beyond a patient’s bank balance. Read More ›
Oncologists Don’t Have the Luxury of Not Discussing Financial Toxicity with Patients
By Chase Doyle
Financial Toxicity, Value-Based Care
September 2017, Vol 7, No 9
As the cost of cancer care continues to rise, greater transparency throughout the process of drug pricing and drug payment needs to become part of the clinical discussion, said Leonard Saltz, MD, Chief, Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center, New York City, at the 2017 ASCO annual meeting. Read More ›

Page 1 of 2